| GENERIC NAME | This data is not available for free |
| STRUCTURE | 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b] [1,5]benzodiazepine. |
| INDICATION'S | Schizophrenia & BiPolar Disorder |
| MECHANISM OF ACTION | Dopamine & Serotonin Receptor |
| SALES VALUE | 2004: US$ 4.4 Billion |
| SIDE EFFECT'S |
- Diabetes - Weight Gain |
| STATUS | US Patent Expiration Date: 05.22.2012 |
| COMPANY | This data is not available for free |
| PATENT NUMBER | This data is not available for free |
|
Want more information ? Interested in the hidden information ? Click here and do your request. |